Thank you, Mr. Chair.
I want to return to the issue over the Canadian Institute for Scientific and Technical Information. Biomedical Commercialization Canada worked with a company called Fermion on creating security measures for airports after 9/11. They've actually commercialized the product and it has gone to the United States quite often.
What I really get concerned about is why we would want to bring in a whole new regime at a time when stability is really one of the biggest assets companies are asking for right now. On the strategic review that was initiated and that has led to this decision of cutting the fund by 50%, and then having another 20% spun off into a private company, has that been completely signed off on, or is there a chance to revisit this?
I am really concerned. You're right, because we're into the patents in Canada. We have very few patents in Canada that actually go to market. Maybe you can provide a little more information on that.